Literature DB >> 17686656

Validation of the University of California San Francisco Oral Cancer Pain Questionnaire.

Antonia Kolokythas1, S Thaddeus Connelly, Brian L Schmidt.   

Abstract

UNLABELLED: The aim of this study was to validate the published University of California San Francisco (UCSF) Oral Cancer Pain Questionnaire. To test for validity of the questionnaire, 16 patients with oral cancer completed the 8-item questionnaire immediately before and after treatment (surgical resection) of their oral cancer. For all 8 questions, the difference between mean preoperative and mean postoperative responses were statistically significant (P < .05), confirming the validity of the questionnaire to measure oral cancer pain. Internal consistency of the questionnaire was evaluated by using Cronbach's alpha, which provides an estimate of reliability based on all correlations between the items (questions) of the instrument (questionnaire). In the oral cancer pain questionnaire, questions 1, 3, and 5 evaluate the intensity, sharpness, and throbbing nature of pain when the patient is not engaged in oral function (talking, eating, and drinking). Questions 2, 4, and 6 measure the intensity, sharpness, and throbbing nature of pain during oral function. Cronbach's alpha for questions 1, 3, and 5 is 0.87 and Cronbach's alpha for questions 2, 4, and 6 is 0.94; values greater than 0.7 indicate reliability. In this study, we have validated the UCSF Oral Cancer Pain Questionnaire as an effective tool in quantifying pain from oral cancer. PERSPECTIVE: The study validates an oral cancer pain questionnaire. The questionnaire can be used to reliably measure pain levels before and after surgical resection in patients with oral cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17686656      PMCID: PMC2227312          DOI: 10.1016/j.jpain.2007.06.012

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  18 in total

1.  A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis.

Authors:  E Hammerlid; K Bjordal; M Ahlner-Elmqvist; M Boysen; J F Evensen; A Biörklund; M Jannert; S Kaasa; M Sullivan; T Westin
Journal:  Laryngoscope       Date:  2001-04       Impact factor: 3.325

2.  Peripheral endothelin A receptor antagonism attenuates carcinoma-induced pain.

Authors:  Brian L Schmidt; Victoria Pickering; Stanley Liu; Phuong Quang; John Dolan; S Thaddeus Connelly; Richard C K Jordan
Journal:  Eur J Pain       Date:  2006-06-27       Impact factor: 3.931

3.  A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data.

Authors:  K Bjordal; M Ahlner-Elmqvist; E Hammerlid; M Boysen; J F Evensen; A Biörklund; M Jannert; T Westin; S Kaasa
Journal:  Laryngoscope       Date:  2001-08       Impact factor: 3.325

4.  How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment?

Authors:  M A List; J Stracks; L Colangelo; P Butler; N Ganzenko; D Lundy; P Sullivan; D Haraf; M Kies; W Goodwin; E E Vokes
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

5.  Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous system.

Authors:  Mary Ann C Sabino; Nancy M Luger; David B Mach; Scott D Rogers; Matthew J Schwei; Patrick W Mantyh
Journal:  Int J Cancer       Date:  2003-05-01       Impact factor: 7.396

6.  A national survey of health-related quality of life questionnaires in head and neck oncology.

Authors:  A N Kanatas; S N Rogers
Journal:  Ann R Coll Surg Engl       Date:  2004-01       Impact factor: 1.891

7.  Endothelin and the tumorigenic component of bone cancer pain.

Authors:  C M Peters; T H Lindsay; J D Pomonis; N M Luger; J R Ghilardi; M A Sevcik; P W Mantyh
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

8.  Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.

Authors:  Mary Ann C Sabino; Joseph R Ghilardi; Joost L M Jongen; Cathy P Keyser; Nancy M Luger; David B Mach; Christopher M Peters; Scott D Rogers; Matthew J Schwei; Carmen de Felipe; Patrick W Mantyh
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

9.  Greek McGill Pain Questionnaire: validation and utility in cancer patients.

Authors:  Kyriaki Mystakidou; Efi Parpa; Eleni Tsilika; Ourania Kalaidopoulou; Stavroula Georgaki; Antonis Galanos; Lambros Vlahos
Journal:  J Pain Symptom Manage       Date:  2002-10       Impact factor: 3.612

10.  Psychological distress in head and neck cancer patients 7-11 years after curative treatment.

Authors:  K Bjordal; S Kaasa
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more
  25 in total

Review 1.  Mechanism of cancer pain.

Authors:  Brian L Schmidt; Darryl T Hamamoto; Donald A Simone; George L Wilcox
Journal:  Mol Interv       Date:  2010-06

Review 2.  Head and neck cancer pain: systematic review of prevalence and associated factors.

Authors:  Tatiana V Macfarlane; Tanja Wirth; Sriyani Ranasinghe; Kim W Ah-See; Nick Renny; David Hurman
Journal:  J Oral Maxillofac Res       Date:  2012-04-01

Review 3.  Biologic mechanisms of oral cancer pain and implications for clinical therapy.

Authors:  C T Viet; B L Schmidt
Journal:  J Dent Res       Date:  2011-10-04       Impact factor: 6.116

4.  Smoking status and pain level among head and neck cancer patients.

Authors:  Henrietta L Logan; Roger B Fillingim; Linda M Bartoshuk; Pamela Sandow; Scott L Tomar; John W Werning; William M Mendenhall
Journal:  J Pain       Date:  2009-12-16       Impact factor: 5.820

5.  The dolognawmeter: a novel instrument and assay to quantify nociception in rodent models of orofacial pain.

Authors:  John C Dolan; David K Lam; Stacy H Achdjian; Brian L Schmidt
Journal:  J Neurosci Methods       Date:  2010-01-21       Impact factor: 2.390

6.  Legumain Induces Oral Cancer Pain by Biased Agonism of Protease-Activated Receptor-2.

Authors:  Nguyen Huu Tu; Dane D Jensen; Bethany M Anderson; Elyssa Chen; Nestor N Jimenez-Vargas; Nicole N Scheff; Kenji Inoue; Hung D Tran; John C Dolan; Tamaryn A Meek; Morley D Hollenberg; Cheng Z Liu; Stephen J Vanner; Malvin N Janal; Nigel W Bunnett; Laura E Edgington-Mitchell; Brian L Schmidt
Journal:  J Neurosci       Date:  2020-11-10       Impact factor: 6.167

7.  Assessment of oral cancer pain, anxiety, and quality of life of oral squamous cell carcinoma patients with invasive treatment procedure.

Authors:  Endang Sjamsudin; Tantry Maulina; Ahmad Cipta; Aulia Iskandarsyah; Andri Hardianto; Mantra Nandini; Alwin Kasim; Harmas Yazid Yusuf
Journal:  Oral Maxillofac Surg       Date:  2018-01-13

Review 8.  The Neurobiology of Cancer Pain.

Authors:  Brian L Schmidt
Journal:  J Oral Maxillofac Surg       Date:  2015-12       Impact factor: 1.895

9.  The Histopathology of Oral Cancer Pain in a Mouse Model and a Human Cohort.

Authors:  K Naik; M N Janal; J Chen; D Bandary; B Brar; S Zhang; J C Dolan; B L Schmidt; D G Albertson; A Bhattacharya
Journal:  J Dent Res       Date:  2020-10-08       Impact factor: 6.116

10.  TMPRSS2, a novel membrane-anchored mediator in cancer pain.

Authors:  David K Lam; Dongmin Dang; Andrea N Flynn; Markus Hardt; Brian L Schmidt
Journal:  Pain       Date:  2015-05       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.